Lessee, Operating Lease, Liability, to be Paid, Year Four in USD of ABVC BIOPHARMA, INC. from Q2 2023 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
ABVC BIOPHARMA, INC. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and change rate from Q2 2023 to Q3 2025.
- ABVC BIOPHARMA, INC. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 30 Sep 2025 was $50.9K.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)